Rhythm Pharmaceuticals Inc header image

Rhythm Pharmaceuticals Inc

RYTM

Equity

ISIN null / Valor 25337263

NASDAQ (2026-10-06)

USD 90.77-1.82%

Rhythm Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare genetic disorders of obesity, specifically those related to the melanocortin-4 receptor (MC4R) pathway. These disorders are distinct from general obesity and are characterized by early-onset, severe obesity and hyperphagia, a condition marked by an insatiable hunger. The company's primary focus is on addressing these rare MC4R pathway impairments to provide targeted therapeutic solutions for patients suffering from these debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-7.25%1Y

288%3Y

666%5Y

Performance

46.2%1Y

53.1%3Y

73.4%5Y

Volatility

6250 M

Market cap (USD)

992,872

Daily traded volume (Shares)

56.78 / 55.07

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

5.00

Society:

5.00

Nature:

2.00

Adrian Pusz

Switzerland, 20 Apr 2025

Rhythm develops what will always be needed - rare disease therapies

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc

IQVIA Holdings Inc Valor: 39103858

Annual Return

-50%0%+50%

Risk level

110

-2.30%USD 259.98

Arvinas Inc

Arvinas Inc Valor: 43526042

Annual Return

-50%0%+50%

Risk level

110

-2.01%USD 7.31

AstraZeneca PLC

AstraZeneca PLC Valor: 982352

Annual Return

-50%0%+50%

Risk level

110

1.65%GBP 119.58

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

0.70%GBP 10.12

Envista Holdings Corporation

Envista Holdings Corporation Valor: 49153522

Annual Return

-50%0%+50%

Risk level

110

-0.30%USD 23.27

Humana Inc

Humana Inc Valor: 940174

Annual Return

-50%0%+50%

Risk level

110

0.05%USD 404.27

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Valor: 2324471

Annual Return

-50%0%+50%

Risk level

110

2.60%GBP 16.20

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

-0.67%GBP 27.04

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd Valor: 2318407

Annual Return

-50%0%+50%

Risk level

110

0.00%GBP 0.54

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

-2.67%USD 1.46

SIX

FactSet

Clearbit

Logos provided by Clearbit